Advancing the Ever-Evolving ED&I Movement Within the Precision Medicine Community to Foster Collaboration, Advocate Membership & Accelerate Innovation to Meaningfully Embed Inclusion Within Personalized Healthcare
This Event Ran Monday, 27 September
8.30am - 12.30pm EDT | 5.30am – 9.30am PDT
4 years on from when the #MeToo movement got reignited, a year on from when the world united behind the BLM movement, and in a year still reeling from the effects of COVID19, how do we continue to shine a light on the crucial and ever-evolving ED&I conversations?
For the third consecutive year, the Equity, Diversity & Inclusion in Precision Medicine workshop brought together 450+ global precision medicine decision makers to continue the movement and drive forward our community’s commitment to ED&I within our teams, functions and wider businesses.
With 30+ precision medicine leaders joining the 2021 expert speaker faculty, this event sharpened leadership skills and showcased the tools to create inclusive and empowering working environments within your organizations. Industry leaders gathered to advance the ever-evolving ED&I movement within the precision medicine community to foster collaboration, advocate membership and accelerate innovation to meaningfully embed inclusion within personalized healthcare.
What Was Discussed?
The Key to Success – Becoming a Culturally Intelligent Global Organization
Effective Leadership & Mentorship Structures to Foster Diversity, Equity & Inclusion Across Your Organization
From Making Your Pledge to Implementation: How Is Your Organization Embedding Diversity, Equity & Inclusion Across All Internal Layers?
Transforming the Recruitment Process & Returning To Work In the Post-COVID19 Era – Further Accelerating Our Industry’s Journey to Becoming Truly Equal, Diverse & Inclusive
Your Expert Speakers Include:
Director, Research & Development
Diversity & Inclusion Partner
Roche Diagnostic Operations
Vice President, Global Head Precision Medicine, Oncology Business Unit
Director & Head of Molecular Biomarker & Genomics, Global Clinical Biomarkers & Companion Diagnostics
Head of CDx Cell & Gene Therapies Oncology
Vice President, BioPharma Business Development
Senior Director of Inclusion & Diversity, North America
Vice President, Public Affairs
Senior Vice President, Translational Research & Early Development
Senior Vice President & General Counsel
President, Agilent CrossLab Group
Associate Vice President, Diversity & Inclusion
Vice President, Preclinical & Translational Research
Vice President, Precision Medicine
Bristol Myers Squibb
Vice President, Biomarker Sciences
Associate Vice President, Head of Global Clinical Affairs